The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Blood-based genomic profiling of cell-free DNA (cfDNA) to identify microsatellite instability (MSI-H), tumor mutational burden (TMB) and Wnt/B-Catenin pathway alterations in patients with gastrointestinal (GI) tract cancers.
 
James Isaacs
No Relationships to Disclose
 
Andrew B. Nixon
Consulting or Advisory Role - Kanghong Pharma; Lilly; Pfizer
Research Funding - Acceleron Pharma; Amgen; AstraZeneca/MedImmune; Eureka Therapeutics; Genentech/Roche; Leadiant Biosciences; medpacto; Novartis; Seagen; TRACON Pharma
Patents, Royalties, Other Intellectual Property - Patent (Inst); Patent Pending (Inst)
Travel, Accommodations, Expenses - TRACON Pharma
 
Emily Bolch
No Relationships to Disclose
 
Katie Quinn
Employment - Guardant Health
 
Kimberly Banks
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
Patents, Royalties, Other Intellectual Property - Guardant Health
 
Brent Allen Hanks
Stock and Other Ownership Interests - Bellicum Pharmaceuticals
Honoraria - CE Concepts; Duke Oncology Network; Virginia Oncology Associates
Consulting or Advisory Role - Fujifilm; G1 Therapeutics; Gerson Lehrman Group; Guidepoint Global
Speakers' Bureau - CE Concepts; Merck
Research Funding - AstraZeneca; D3; GlaxoSmithKline; Leap Therapeutics; Merck; OncoMed; Tempest Therapeutics
Patents, Royalties, Other Intellectual Property - Inhibiting paracrine Wnt ligand signaling to augment checkpoint inhibitor immunotherapy. (Inst); Modulating the metabolism of dendritic cells to enhance anti-tumor immunity. (Inst)
Expert Testimony - Kinnard, Clayton & Beveridge
Travel, Accommodations, Expenses - Cambridge Healthtech Institute; CE Concepts; Virginia Oncology Associates
 
John H. Strickler
Stock and Other Ownership Interests - OncoMed
Honoraria - Chugai/Roche
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Celgene; Genentech/Roche; OncoMed; Proteus Digital Health; Seagen
Research Funding - Abbvie (Inst); Amgen (Inst); Cascadian Therapeutics (Inst); Exelixis (Inst); Gilead Sciences (Inst); Leap Therapeutics (Inst); Macrogenics (Inst); MedImmune (Inst); Nektar (Inst); OncoMed (Inst); Roche/Genentech (Inst); Seagen (Inst)